BioCentury | Jul 24, 2012
Financial News

PTC Therapeutics raises $30 million

...raised $30 million from existing investors, including Credit Suisse First Boston Equity Partners; HBM BioVentures; Vulcan Ventures...
BioCentury | Apr 10, 2006
Finance

Ebb & Flow

Lion bioscience (FSE:LIO) was Europe's biggest-ever biotech IPO - the company raised E227.9 million ($205.5 million) in August 2000 on the promise of its bioinformatics business. Within a few weeks, the stock more than doubled to...
BioCentury | Jan 2, 2006
Finance

Profiling Perlegen's money

...Maverick Capital; Unilever Technology Ventures; Eli Lilly; BioFrontier; CSK Venture Capital; Biomedical Sciences Investment Fund; Vulcan Ventures...
BioCentury | Dec 12, 2005
Finance

PIPE adventures

...CRIS) 11/16/00 $46.8 $9.00 $3.54 -61% Investors in the renal, neurology and cancer company included Vulcan Ventures...
BioCentury | Nov 11, 2005
Financial News

PTC raises $26.6 million

...million in a series E2 round led by Credit Suisse and HBM BioVentures. Existing investors Vulcan Ventures...
BioCentury | Mar 29, 2004
Strategy

All that Jazz . . .

...and $26.3M on 3/29/03 Infinity $70.0 6/24/02 Chemistry, genomics Advent; Venrock Associates; Prospect Venture Partners; Vulcan Ventures...
BioCentury | Feb 2, 2004
Finance

IPOs: Getting down to business

...million. Principal shareholders include Sevin Rosen Funds (16.2% prior to IPO); CS First Boston (15.9%); Vulcan Ventures...
BioCentury | Oct 27, 2003
Finance

Ebb & Flow

Aderis did not price its IPO as scheduled last week, making it the third tenuous sign at the beginning of the IPO window. The neurological company's deal is now listed as "day-to-day" on the SEC's...
BioCentury | May 5, 2003
Finance

Ebb & Flow

...Signature backer. Other Signature investors included SG Capital Partners; Abingworth; CIBC Capital Partners; Coral Ventures; Vulcan Ventures...
BioCentury | May 5, 2003
Company News

Signature cancer, high throughput screening news

...from SG Capital Partners; Atlas Venture; Prospect Venture Partners; Abingworth; CIBC Capital Partners; Coral Ventures; Vulcan Ventures...
Items per page:
1 - 10 of 45
BioCentury | Jul 24, 2012
Financial News

PTC Therapeutics raises $30 million

...raised $30 million from existing investors, including Credit Suisse First Boston Equity Partners; HBM BioVentures; Vulcan Ventures...
BioCentury | Apr 10, 2006
Finance

Ebb & Flow

Lion bioscience (FSE:LIO) was Europe's biggest-ever biotech IPO - the company raised E227.9 million ($205.5 million) in August 2000 on the promise of its bioinformatics business. Within a few weeks, the stock more than doubled to...
BioCentury | Jan 2, 2006
Finance

Profiling Perlegen's money

...Maverick Capital; Unilever Technology Ventures; Eli Lilly; BioFrontier; CSK Venture Capital; Biomedical Sciences Investment Fund; Vulcan Ventures...
BioCentury | Dec 12, 2005
Finance

PIPE adventures

...CRIS) 11/16/00 $46.8 $9.00 $3.54 -61% Investors in the renal, neurology and cancer company included Vulcan Ventures...
BioCentury | Nov 11, 2005
Financial News

PTC raises $26.6 million

...million in a series E2 round led by Credit Suisse and HBM BioVentures. Existing investors Vulcan Ventures...
BioCentury | Mar 29, 2004
Strategy

All that Jazz . . .

...and $26.3M on 3/29/03 Infinity $70.0 6/24/02 Chemistry, genomics Advent; Venrock Associates; Prospect Venture Partners; Vulcan Ventures...
BioCentury | Feb 2, 2004
Finance

IPOs: Getting down to business

...million. Principal shareholders include Sevin Rosen Funds (16.2% prior to IPO); CS First Boston (15.9%); Vulcan Ventures...
BioCentury | Oct 27, 2003
Finance

Ebb & Flow

Aderis did not price its IPO as scheduled last week, making it the third tenuous sign at the beginning of the IPO window. The neurological company's deal is now listed as "day-to-day" on the SEC's...
BioCentury | May 5, 2003
Finance

Ebb & Flow

...Signature backer. Other Signature investors included SG Capital Partners; Abingworth; CIBC Capital Partners; Coral Ventures; Vulcan Ventures...
BioCentury | May 5, 2003
Company News

Signature cancer, high throughput screening news

...from SG Capital Partners; Atlas Venture; Prospect Venture Partners; Abingworth; CIBC Capital Partners; Coral Ventures; Vulcan Ventures...
Items per page:
1 - 10 of 45